Jennison Associates’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,814,330
Closed -$14.5M 688
2021
Q4
$14.5M Sell
1,814,330
-27,248
-1% -$218K 0.01% 409
2021
Q3
$15.4M Sell
1,841,578
-758,849
-29% -$6.35M 0.01% 402
2021
Q2
$17.5M Hold
2,600,427
0.01% 388
2021
Q1
$17.2M Sell
2,600,427
-16,046
-0.6% -$106K 0.01% 374
2020
Q4
$11M Sell
2,616,473
-17,667
-0.7% -$74.2K 0.01% 393
2020
Q3
$12.6M Buy
2,634,140
+8,626
+0.3% +$41.3K 0.01% 353
2020
Q2
$16M Buy
2,625,514
+13,208
+0.5% +$80.3K 0.01% 319
2020
Q1
$14.3M Sell
2,612,306
-18,320
-0.7% -$101K 0.02% 296
2019
Q4
$26.1M Buy
2,630,626
+11,614
+0.4% +$115K 0.03% 275
2019
Q3
$15.1M Sell
2,619,012
-229,916
-8% -$1.32M 0.02% 348
2019
Q2
$25.9M Sell
2,848,928
-39,665
-1% -$361K 0.03% 302
2019
Q1
$40.1M Sell
2,888,593
-106,712
-4% -$1.48M 0.04% 261
2018
Q4
$47.3M Sell
2,995,305
-2,789
-0.1% -$44K 0.05% 216
2018
Q3
$58M Buy
2,998,094
+16,889
+0.6% +$327K 0.05% 235
2018
Q2
$21.8M Buy
2,981,205
+30,831
+1% +$225K 0.02% 385
2018
Q1
$9.07M Buy
2,950,374
+314,822
+12% +$968K 0.01% 462
2017
Q4
$8.5M Buy
2,635,552
+178,192
+7% +$575K 0.01% 471
2017
Q3
$11.9M Sell
2,457,360
-15,248
-0.6% -$74K 0.01% 463
2017
Q2
$12.9M Sell
2,472,608
-112,439
-4% -$585K 0.01% 453
2017
Q1
$12.9M Hold
2,585,047
0.01% 470
2016
Q4
$12.7M Sell
2,585,047
-31,920
-1% -$156K 0.01% 458
2016
Q3
$17.5M Sell
2,616,967
-55,410
-2% -$370K 0.02% 429
2016
Q2
$12.9M Sell
2,672,377
-2,467
-0.1% -$11.9K 0.01% 440
2016
Q1
$13.1M Buy
2,674,844
+1,673,070
+167% +$8.16M 0.01% 437
2015
Q4
$8.7M Buy
1,001,774
+33,019
+3% +$287K 0.01% 479
2015
Q3
$14.1M Buy
968,755
+2,322
+0.2% +$33.8K 0.01% 474
2015
Q2
$16.1M Buy
966,433
+2,968
+0.3% +$49.5K 0.01% 473
2015
Q1
$21.1M Buy
963,465
+393,507
+69% +$8.61M 0.02% 433
2014
Q4
$12.4M Sell
569,958
-60,412
-10% -$1.31M 0.01% 472
2014
Q3
$10.8M Buy
+630,370
New +$10.8M 0.01% 473